• Written by ajiang
  • June 14, 2010 at 5:09 pm
  • Gershon Capital provides advisory services to healthcare and life science companies through its relationship with Gershon & Company, our consulting arm founded in 1999. The Gershon & Company advisory group leverages its senior management team and industry networks to bring sector expertise, investment experience, and regulatory, scientific and medical knowledge to emerging healthcare and life science companies, hedge funds, private equity firms, and government.

    Gershon Capital assists healthcare and life science companies achieve their business objectives through integrated reimbursement, clinical research, regulatory affairs, and marketing strategies. Through the integration of these key functional areas, we have the ability to assist our clients in the full array of activities involved in successfully moving a product from concept to commercialization. Strategic thinking and integrated operations result in approved products that rest on a foundation of strong clinical claims and data to support optimal reimbursement and impact market share.

    Patty Telgener, Director of Pricing and Reimbursement, Gershon Capital & Cie.


  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!